RNA Manufacturing Solutions

  1. LC/MS/MS Vs. LC/HRMS: Identifying And Quantifying Oligonucleotides 2/5/2025

    As OGNT-based therapeutics continue to gain traction in drug development, precise identification and quantification are essential for ensuring their efficacy and safety.

  2. The Device Of Choice For Applications Requiring Higher Yield 10/16/2025

    High-flux membranes enable scalable filtration of biologics even under harsh conditions. Ideal for high-viscosity feeds, these cassettes support efficient processing and reliable cleanability.

  3. in vivo-jetRNA®+ 9/14/2022

    Efficient: 100% mRNA encapsulation leading to comparable LNP delivery results
    in vivo-jetRNA®+ is the reagent of choice to deliver mRNA to various organs. This is attributable to its intrinsic properties: in vivo-jetRNA®+ protects its payload against ubiquitous endonucleases, prevent non-specific interactions with proteins and promote efficient cell entry.

  4. Achieve Higher Targeted Concentrations 9/30/2025

    High-concentration protein therapies offer patient and clinician benefits, but processing them introduces pressure-related challenges. Learn more about how pressure impacts final concentration outcomes.

  5. Groundbreaking Cryogenic Freezer Technology 3/7/2023

    Examine the benefits of a new cryogenic storage tank and how this innovative technology will mitigate risk in the cell and gene therapy supply chain.

  6. CD34+ HSC LNP Kits 4/24/2025

    Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  7. Your Vision. Our Pioneering Experience. 3/10/2021

    PRECISION ADVANCE, a collection of interconnected services and complementary teams, uniquely focuses on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market.

  8. A Next-Gen Polymerase For Self-Amplifying mRNA 5/13/2026

    Expanding on our innovative RNA polymerases, the Prima RNApols® ExTend Cap AU kit is designed to maximize yield and capping efficiency, and minimize dsRNA, during in vitro transcription (IVT) of saRNA.

  9. Complete Solutions For Every Step Of Pharmaceutical Development 1/12/2023

    By combining disruptive technology platforms with unparalleled genomic medicine development expertise, we're positioned to accelerate the development of LNP formulations and drug products.

  10. Accelerate Your Oligonucleotide Development And Scale-Up Goals 2/10/2023

    Discover the platform for oligonucleotide development and scale-up that is the result of 30 years of collaboration with leading oligonucleotide pharma. Explore this solution's benefits, specifications, and more.